Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia
Although the anti-CCR4 antibody mogamulizumab (moga) shows striking antitumor activity against adult T cell leukemia (ATL), it can also cause fatal immunological pathology such as severe skin rash and graft-versus-host disease, which might be attributed to depletion of CCR4+ regulatory T cells. We p...
Main Authors: | Takero Shindo, Kazutaka Kitaura, Hiroshi Ureshino, Kazuharu Kamachi, Masaharu Miyahara, Kazuko Doi, Tatsuro Watanabe, Eisaburo Sueoka, Tadasu Shin-I, Ryuji Suzuki, Shinya Kimura |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2018-03-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1405204 |
Similar Items
-
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
by: Ollila TA, et al.
Published: (2019-02-01) -
Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy
by: Taku Fujimura, et al.
Published: (2018-01-01) -
Quantitatively immunological characterization of mogamulizumab skin disorders in ATL patients
by: Asahi Ito, et al.
Published: (2019-08-01) -
Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021-08-01) -
Impressive continuous complete response after mogamulizumab in a heavily pre-treated Sézary syndrome patient
by: Pier Luigi Zinzani, et al.
Published: (2020-06-01)